
The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma
Author(s) -
Sabina Dizdarevic,
Mark Tülchinsky,
V. R. McCready,
Jasna Mihailović,
Sobhan Vinjamuri,
J Buscombe,
ST Lee,
Savvas Frangos,
Mike Sathekge,
Q. H. Siraj,
Partha S Choudhury,
HeeSeung Bom,
Maja Franceschi,
Ana Ugrinska,
Diana Páez,
Raza Hussain,
Joseph L. Mailman,
Markus Luster,
Irene Virgolini
Publication year - 2019
Publication title -
world journal of nuclear medicine
Language(s) - English
Resource type - Journals
eISSN - 1607-3312
pISSN - 1450-1147
DOI - 10.4103/wjnm.wjnm_117_18
Subject(s) - medicine , radioiodine therapy , position statement , radionuclide therapy , thyroid carcinoma , thyroid cancer , medical physics , targeted therapy , thyroid , nuclear medicine , oncology , family medicine , cancer